These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 10863557)
1. Cytoprotective properties of nisoldipine and amlodipine against oxidative endothelial cell injury. Mak IT; Zhang J; Weglicki WB Ann N Y Acad Sci; 2000; 899():403-6. PubMed ID: 10863557 [No Abstract] [Full Text] [Related]
2. Protective effects of dihydropyridine Ca-blockers against endothelial cell oxidative injury due to combined nitric oxide and superoxide. Mak IT; Zhang J; Weglicki WB Pharmacol Res; 2002 Jan; 45(1):27-33. PubMed ID: 11820858 [TBL] [Abstract][Full Text] [Related]
3. The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells. Batova S; DeWever J; Godfraind T; Balligand JL; Dessy C; Feron O Cardiovasc Res; 2006 Aug; 71(3):478-85. PubMed ID: 16814758 [TBL] [Abstract][Full Text] [Related]
4. Effects of the calcium channel blocker amlodipine on serum and aortic cholesterol, lipid peroxidation, antioxidant status and aortic histology in cholesterol-fed rabbits. Turgan N; Habif S; Kabaroğlu CG; Mutaf I; Ozmen D; Bayindir O; Uysal A J Biomed Sci; 2003; 10(1):65-72. PubMed ID: 12566988 [TBL] [Abstract][Full Text] [Related]
5. Amlodipine treatment prevents angiotensin II-induced human umbilical vein endothelial cell apoptosis. Bian YF; Yang HY; Yang ZM; Gao F; Zhang NN; Xiao CS Arch Med Res; 2011 Jan; 42(1):22-7. PubMed ID: 21376258 [TBL] [Abstract][Full Text] [Related]
6. Amlodipine inhibits expression of matrix metalloproteinase-1 and its inhibitor in human vascular endothelial cells. Ikeda U; Hojo Y; Ueno S; Arakawa H; Shimada K J Cardiovasc Pharmacol; 2000 Jun; 35(6):887-90. PubMed ID: 10836722 [TBL] [Abstract][Full Text] [Related]
7. Amlodipine releases nitric oxide from canine coronary microvessels: An unexpected mechanism of action of a calcium channel-blocking agent. Dhein S; Salameh A Circulation; 1999 Aug; 100(9):1011. PubMed ID: 10468534 [No Abstract] [Full Text] [Related]
8. Cholesterol, calcium and atherosclerosis: is there a role for calcium channel blockers in atheroprotection? Tulenko TN; Laury-Kleintop L; Walter MF; Mason RP Int J Cardiol; 1997 Dec; 62 Suppl 2():S55-66. PubMed ID: 9488196 [TBL] [Abstract][Full Text] [Related]
9. Nifedipine and nisoldipine modulate membrane potential of vascular endothelium via a myo-endothelial pathway. Muraki K; Watanabe M; Imaizumi Y Life Sci; 2000 Nov; 67(26):3163-70. PubMed ID: 11191623 [TBL] [Abstract][Full Text] [Related]
10. Amlodipine protects rat ventricular cardiomyoblast H9c2 From hypoxia-induced apoptosis and restores oxidative balance by Akt-1-dependent manner. Nehra S; Bhardwaj V; Saraswat D J Cardiovasc Pharmacol; 2014 Oct; 64(4):375-84. PubMed ID: 24921631 [TBL] [Abstract][Full Text] [Related]
11. Translocation of endothelial nitric oxide synthase: another feat of amlodipine, a cardiovascular jack-of-all-trades. Mayer B Cardiovasc Res; 2006 Aug; 71(3):411-3. PubMed ID: 16820143 [No Abstract] [Full Text] [Related]
12. Mechanisms of plaque stabilization for a charged calcium channel blocker in coronary artery disease. Mason RP Pharmacotherapy; 2001 Sep; 21(9 Pt 2):209S-215S. PubMed ID: 11560191 [TBL] [Abstract][Full Text] [Related]
13. Amlodipine-induced reduction of oxidative stress in the brain is associated with sympatho-inhibitory effects in stroke-prone spontaneously hypertensive rats. Hirooka Y; Kimura Y; Nozoe M; Sagara Y; Ito K; Sunagawa K Hypertens Res; 2006 Jan; 29(1):49-56. PubMed ID: 16715653 [TBL] [Abstract][Full Text] [Related]
14. Vascular pleiosynergy--does it really work? Császár A Curr Vasc Pharmacol; 2007 Oct; 5(4):302-4. PubMed ID: 17979796 [TBL] [Abstract][Full Text] [Related]
15. Voltage-dependent N-type Ca2+ channels in endothelial cells contribute to oxidative stress-related endothelial dysfunction induced by angiotensin II in mice. Nishida M; Ishikawa T; Saiki S; Sunggip C; Aritomi S; Harada E; Kuwahara K; Hirano K; Mori Y; Kim-Mitsuyama S Biochem Biophys Res Commun; 2013 May; 434(2):210-6. PubMed ID: 23537646 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of atherosclerotic plaque stabilization for a lipophilic calcium antagonist amlodipine. Mason RP Am J Cardiol; 2001 Nov; 88(10A):2M-6M. PubMed ID: 11705416 [TBL] [Abstract][Full Text] [Related]
17. The role of the endothelium on calcium-entry blockade in coronary vasospasm. Duprez D Verh K Acad Geneeskd Belg; 1989; 51(4):295-313. PubMed ID: 2603545 [TBL] [Abstract][Full Text] [Related]
18. Amlodipine suppresses Ang-II-induced endothelium dysfunction by diminishing ROCK1 expression. Xu R; Cai A; Zheng D; Qiu R; Li L; Zhou Y; Feng Y; Mai W Clin Exp Hypertens; 2016; 38(2):166-72. PubMed ID: 26452457 [TBL] [Abstract][Full Text] [Related]
19. [Membrane biophysical interaction of amlodipine and antioxidant properties]. Mason RP; Trumbore MW; Mason PE Drugs; 2000; 59 Spec No 2():9-16. PubMed ID: 11002854 [TBL] [Abstract][Full Text] [Related]
20. Antioxidant effect of a new calcium antagonist, azelnidipine, in cultured human arterial endothelial cells. Shinomiya K; Mizushige K; Fukunaga M; Masugata H; Ohmori K; Kohno M; Senda S J Int Med Res; 2004; 32(2):170-5. PubMed ID: 15080021 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]